ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

STUDY TO REVEAL THE MEAN REDUCTION IN HOMOCYSTEINE LEVELS IN TYPE II DIABETES MELLITUS PATIENTS ON VITAMIN B12 THERAPY

Dr Haleema Anwar, Dr Arslan Tarique, Dr Hafiz Humayun Rasool

Abstract: Objective: To determine the mean decrease in homocysteine levels in patient of type II diabetes mellitus on vitamin B12 therapy. Study design: A quasi experimental study. Place and Duration: In the Medicine Unit II of Services Hospital Lahore for Six months duration from July 2018 to January 2019. Methods: 72 total patients were selected for the study during the six-month study period. Blood samples were taken for fasting blood glucose and homocysteine to evaluate inclusion criteria at the beginning of the study. Patients were given vitamin B12 500 mg / day for 6 weeks. Fasting homocysteine levels were determined again after 6 weeks. To ensure that bias is minimized, sample collection, transport and laboratory procedures are standardized. Using SPSS version 20.0 data analysis was done. Results: The mean difference in homocysteine before and after treatment was 0.39 (95% CI 0.36 to 0.42) and a statistically significant p value of <0.001. Conclusion: It was concluded that vitamin B12 have an important role in decreasing levels of homocysteine in patients with type II diabetes. Key words: Homocysteine levels, vitamin B12, diabetes mellitus type II.

FULL TEXT